BB BIOTECH EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
Transparency directive : regulatory news
|
EQS-News: BB BIOTECH AG
/ Key word(s): AGM/EGM/Dividend
Media release of March 21, 2024 Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today. Shareholders voted in favor of the proposal to pay out a dividend of CHF 2.00 gross per share. Payment will be made on March 27, 2024, the record date is March 26, 2024 and the ex-dividend date is March 25, 2024. Dr. Thomas von Planta, former member of the Board of Directors, was elected as the new Chairman of the Board of Directors, succeeding Dr. Erich Hunziker, who did not stand for re-election. The Board of Directors thanks him for his valuable contribution and personal commitment to BB Biotech over the past 13 years. In addition, Camilla Soenderby was elected as a new member of the Board of Directors. The shareholders re-elected the current Board members Dr. Clive Meanwell, Laura Hamill, Dr. Pearl Huang and Prof. Dr. Mads Krogsgaard Thomsen for a further one-year term of office. Investor Relations Media Relations TE Communications AG, Bleichestrasse 11, 9000 St. Gallen, Switzerland, tel. +41 79 423 22 28
www.bbbiotech.com Company profile
21.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | BB BIOTECH AG |
| Schwertstrasse 6 | |
| 8200 Schaffhausen | |
| Switzerland | |
| Phone: | +41 52 624 08 45 |
| E-mail: | info@bbbiotech.com |
| Internet: | www.bbbiotech.ch |
| ISIN: | CH0038389992 |
| WKN: | A0NFN3 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Mailand, SIX |
| EQS News ID: | 1864639 |
| End of News | EQS News Service |
|
|
1864639 21.03.2024 CET/CEST